BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3103357)

  • 1. Distribution pattern of concanavalin A on carcinoma cells, histiocytes and mesothelial cells from effusions.
    Lubínski J
    Acta Cytol; 1987; 31(2):99-103. PubMed ID: 3103357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new epithelial membrane antigen (Calam 27) as a marker of carcinoma in serous effusions.
    Gioanni J; Caldani C; Zanghellini E; Mazeau C; Duplay H; Ferrua B; Schneider M
    Acta Cytol; 1991; 35(3):315-9. PubMed ID: 2042433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transmission and scanning electron microscopic studies of cells in effusions.
    Domagala W; Woyke S
    Acta Cytol; 1975; 19(3):214-24. PubMed ID: 1056674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive effusion cytology as the initial presentation of malignancy.
    Monte SA; Ehya H; Lang WR
    Acta Cytol; 1987; 31(4):448-52. PubMed ID: 3604540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interval between the diagnosis of malignancy and the development of effusions, with reference to the role of cytologic diagnosis.
    van de Molengraft FJ; Vooijs GP
    Acta Cytol; 1988; 32(2):183-7. PubMed ID: 3348059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The binding of fluorescent-labelled concanavalin A to human breast tissue--a marker of differentiation.
    Walker RA
    J Pathol; 1983 Jul; 140(3):255-65. PubMed ID: 6408231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution and movement of concanavalin-A receptors on the surface of cancer cells from human effusions.
    Lubiński J; Czerniak B
    Acta Med Pol; 1979; 20(4):429-30. PubMed ID: 546110
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunocytochemical detection of ovarian carcinoma cells in serous effusions.
    Cuijpers VM; Boerman OC; Salet van de Pol MR; Vooijs GP; Poels LG; Ramaekers FC
    Acta Cytol; 1993; 37(3):272-9. PubMed ID: 8498129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Presumption of primary sites from cytological findings--with reference to adenocarcinoma cells in the effusions in body cavities].
    Takamura Y; Tajima M
    Rinsho Byori; 1990 Nov; Suppl 87():126-40. PubMed ID: 2287083
    [No Abstract]   [Full Text] [Related]  

  • 10. Tumor type and single-cell/mesothelial-like cell pattern of breast carcinoma metastases in pleural and peritoneal effusions.
    Antic T; Gong Y; Sneige N
    Diagn Cytopathol; 2012 Apr; 40(4):311-5. PubMed ID: 22431319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electron microscopic studies of cells in pleural and peritoneal effusions.
    Murad TM
    Acta Cytol; 1973; 17(5):401-9. PubMed ID: 4517952
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cells affected by apoptosis in effusions of tumor origin in man].
    Gotzos V; Cappelli-Gotzos B; Conti G
    Ann Pathol; 1984; 4(3):217-21. PubMed ID: 6477687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cytologic diagnosis of malignant neoplasms in pleural and peritoneal effusions.
    Sears D; Hajdu SI
    Acta Cytol; 1987; 31(2):85-97. PubMed ID: 3469856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local immunotherapy with interferon-alpha in metastatic pleural and peritoneal effusions: correlation with immunologic parameters.
    Stathopoulos GP; Baxevanis CN; Papadopoulos NG; Zarkadis IK; Papacostas P; Michailakis E; Tsiatas ML; Papamichail M
    Anticancer Res; 1996; 16(6B):3855-60. PubMed ID: 9042270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrastructure of the surface coat of the mesothelial and cancer cells from human effusions.
    Czerniak B
    Mater Med Pol; 1984; 16(1):3-7. PubMed ID: 6527570
    [No Abstract]   [Full Text] [Related]  

  • 16. Ultrastructural studies of cells in body cavity effusions.
    Bewtra C; Greer KP
    Acta Cytol; 1985; 29(3):226-38. PubMed ID: 3859122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fc receptors in the differentiation of mesothelial cells from malignant cells in effusions.
    Chandra M; Nayar M
    Acta Cytol; 1990; 34(4):582-3. PubMed ID: 2375229
    [No Abstract]   [Full Text] [Related]  

  • 18. Survival of patients with malignancy-associated effusions.
    van de Molengraft FJ; Vooijs GP
    Acta Cytol; 1989; 33(6):911-6. PubMed ID: 2588923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbohydrate antigen expression in primary tumors, metastatic lesions, and serous effusions from patients diagnosed with epithelial ovarian carcinoma: evidence of up-regulated Tn and Sialyl Tn antigen expression in effusions.
    Davidson B; Berner A; Nesland JM; Risberg B; Kristensen GB; Tropé CG; Bryne M
    Hum Pathol; 2000 Sep; 31(9):1081-7. PubMed ID: 11014575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Contribution of immunocytochemical marking of benign cells to the diagnosis of serous effusions].
    Gaulier A; Cava E; Chosia MC; Pore G; Marsan C
    Ann Pathol; 1986; 6(4-5):323-8. PubMed ID: 3814272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.